A clinical trial investigated the effects of a new antidepressant drug. Researchers claimed that the drug significantly reduces symptoms of depression compared to a placebo. They based this conclusion on data showing that patients who received the drug reported fewer depressive symptoms than those who received the placebo. However, the study had a high drop-out rate among participants taking the drug.
Given this information, which of the following, if true, would most seriously weaken the researchers' conclusion?